申请人:Du Pont Merck Pharmaceutical Company
公开号:US05225418A1
公开(公告)日:1993-07-06
The present invention relates to novel 5H-[1,2]benzisothiazolo[2,3-a]quinoline-5-ones, processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods of using these compounds for the treatment of inflammatory disorders.
本发明涉及新型5H-[1,2]苯并异噻唑并[2,3-a]喹啉-5-酮,制备这种化合物的方法,含有这种化合物的制药组合物,以及使用这些化合物治疗炎症性疾病的方法。